Physician profile

Nicholas Lim Chow Tom

Transplant Hepatology · Rochester, NY

NPI 1710159363

$396.24

in general payments reported to CMS, 2019-2025

5 companies · $129 in 2025

The $129 reported for 2025 was less than what a typical Transplant Hepatology provider received nationally (typical 2025 total: $508).

See the full distribution for Transplant Hepatology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$323.39

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Penumbra, INC. $150.00 2024 Indigo System
Novo Nordisk INC $128.75 2025
Mallinckrodt Enterprises LLC $72.85 2019
Boston Scientific Corporation $44.64 2023 Therasphere Y90 Glass Microspheres 10 Gbq

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Nicholas Lim Chow Tom

$396.24

in general payments reported 2019-2025

Years
2019-2025
Top company
Penumbra, INC.
Context
The $129 reported for 2025 was less than what a typical Transplant Hepatology provider received nationally (typical 2025 total: $508).

https://glasscript.com/doctor/2792402/nicholas-lim-chow-tom

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.